Lexion vs Ironclad: Which in 2026?
Quick answer: Start with the fact that reframes this: DocuSign completed its acquisition of Lexion on 31 May 2024 for $165 million, and its capability now sits inside DocuSign's platform. So a buyer choosing Lexion is choosing a DocuSign product, which matters if vendor concentration was part of the reasoning. On the products themselves, Lexion was chosen for being light: an in-house team of two could run it without legal ops. Ironclad is deeper on approval routing, has reported figures with a median near $40,000 a year, and is an implementation measured in months.
At a glance
| Lexion | Ironclad | |
|---|---|---|
| Reported price | ~$15,000 to $150,000 a year, quote-based and per user | ~$30,000 to $250,000 a year, marketplace median near $40,000 across 363 recorded purchases |
| Ownership | Part of DocuSign since 31 May 2024 | Independent |
| Priced on | Users | Seats, contract volume and modules |
| Bought for | Light touch; a small in-house team can run it | Depth; approval routing across departments |
| Approval routing | Capable and deliberately simple | Conditional by value, risk and department; the reference implementation |
| Implementation | Weeks, historically its main selling point | Months, with a named internal owner |
| Needs a legal ops function | No | In practice, yes, or somebody acting as one |
| Price transparency | No published price; reported figures available | No published price; reported figures available |
Which one, by buyer
| If you are | Choose | Because |
|---|---|---|
| A small in-house team with nobody to own a rollout | Lexion | It was built so a team of two could run it without legal ops, and that remains its clearest advantage over Ironclad. |
| A business where deals stall in cross-department sign-off | Ironclad | Conditional routing across finance, security and procurement is materially deeper, and no amount of light touch fixes an approval queue. |
| A business deliberately reducing vendor concentration | Ironclad | Lexion is now a DocuSign product. If you already run DocuSign e-signature, choosing it consolidates rather than diversifies. |
| A business already standardised on DocuSign | Lexion | One vendor, one relationship, one renewal. That consolidation is worth real procurement time and the signing capability is already in place. |
| A team that wants per-user rather than volume pricing | Lexion | It charged per user, so growing contract volume did not raise the bill. Ironclad prices partly on volume, which punishes commercial success. |
| A business that needs to read a legacy estate | Neither | Both track best what they created. Evisort or Luminance read the document text, which is what an inherited estate requires. |
One of these is now a DocuSign product
DocuSign announced the acquisition on 6 May 2024 and completed it on 31 May 2024 for $165 million. Lexion's AI and repository capability has been folded into DocuSign's agreement platform.
That matters for a specific reason. A meaningful share of Lexion's customers chose it precisely because it was not one of the incumbents, and the acquisition reverses that. If you are evaluating it now, you are evaluating a DocuSign product.
Whether that is good or bad depends on your position. A business already standardised on DocuSign gains consolidation. A business deliberately spreading vendor risk has lost the reason it shortlisted Lexion in the first place.
Light touch against depth
Lexion's reputation rested on being runnable by a small in-house team with no legal ops function and no months-long deployment. For a team of two that decides whether the tool gets used or shelved.
Ironclad is deeper in the ways that matter at scale, particularly conditional approval routing across departments, and it asks for a corresponding investment: months of implementation and somebody internal owning it.
The question is whether you have that person. Businesses that buy Ironclad without one usually get a partial deployment that never quite becomes the system of record it was bought to be.
Per user against partly per volume
Lexion priced per user, so a business closing more deals did not pay more. Ironclad prices on a mix of seats, contract volume and modules, so commercial success raises the bill.
Neither publishes a rate card. Lexion's reported range was roughly $15,000 to $150,000; Ironclad's reported median sits near $40,000 across 363 recorded purchases, which is the more benchmarkable figure of the two.
Since the acquisition, the relevant question is what DocuSign quotes rather than what Lexion used to, and whether the per-user model survives inside a larger platform's commercial structure. That is worth asking directly.
Frequently asked questions
Is Lexion or Ironclad better?
Lexion for a small in-house team with nobody to own a rollout, since it was built to be run without legal ops. Ironclad where deals stall in cross-department approval, which is the capability it leads on. The acquisition adds a third consideration that is commercial rather than technical.
What happened to Lexion?
DocuSign announced its acquisition on 6 May 2024 and completed it on 31 May 2024 for $165 million. The capability has been folded into DocuSign's agreement management platform, so a buyer evaluating Lexion today is evaluating a DocuSign product.
How much does each cost?
Lexion was reported at approximately $15,000 to $150,000 a year, quote-based and priced per user. Ironclad is reported at $30,000 to $250,000 with a marketplace median near $40,000 across 363 recorded purchases, which makes it the more benchmarkable of the two.
Does the acquisition mean we should avoid Lexion?
Not by itself. It means you should ask different questions: how renewal is handled now, whether the roadmap serves DocuSign's wider platform, and what happens to per-user pricing inside a larger commercial structure. If you already run DocuSign, consolidation is a genuine advantage.
Which needs less internal effort?
Lexion, and it is the main reason people chose it. Ironclad runs to months with somebody internal owning the configuration. A business without that person tends to end up with a partial Ironclad deployment rather than a working one.
Which handles approvals better?
Ironclad, and it is not close. Conditional routing by value, risk and department is the reference implementation in this category. Lexion's approval capability is capable and deliberately simpler, which is a feature for a small team and a limit for a large one.
Do either read contracts we signed years ago?
Not well. Both track best what was created inside them, because their obligation data comes largely from what was captured at creation. If an inherited estate is the problem, Evisort or Luminance read the document text and are the right purchase for it.